Even though Medtronic Inc. does not bill Medicare, the Department of Justice (DOJ) alleges it caused others to submit claims based on coding and billing information it provided for a procedure that was experimental and not reimbursable. In a Feb. 6 DOJ press release, the Minnesota-based device manufacturer is accused of off-label marketing of a…

This content is for Paid Members only.
Login Register